 | • レポートコード：QYR2104Z3703 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、精神障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、自助療法）、用途別市場規模（うつ病、双極性障害、統合失調症、認知症、心的外傷後ストレス障害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・精神障害治療の市場動向 ・企業の競争状況、市場シェア ・精神障害治療の種類別市場規模（治療薬、自助療法） ・精神障害治療の用途別市場規模（うつ病、双極性障害、統合失調症、認知症、心的外傷後ストレス障害、その他） ・精神障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・精神障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・精神障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・精神障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・精神障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc、Eli Lilly and Company、VistaGen Therapeutics、Sanofi S.A、Novartis International AG、Mylan N.V、Amneal Pharmaceuticals LLC、Cipla Ltd、Sun Pharmaceutical Industries Ltd、Glenmark Pharmaceuticals Limited、Lupin Limited、Janssen Pharmaceutica、Bristol Myers Squibb、Sumitomo Dainippon Pharma Co., Ltd） ・結論 |
A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.
These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.
Market Analysis and Insights: Global Mental Disorder Treatment Market
The global Mental Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mental Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mental Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mental Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mental Disorder Treatment market.
Global Mental Disorder Treatment Scope and Market Size
Mental Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mental Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medications
Self-help Therapies
Segment by Application
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan Plc
Eli Lilly and Company
VistaGen Therapeutics
Sanofi S.A
Novartis International AG
Mylan N.V
Amneal Pharmaceuticals LLC
Cipla Ltd
Sun Pharmaceutical Industries Ltd
Sanofi S.A
Novartis International AG
Janssen Pharmaceutica
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mental Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications
1.2.3 Self-help Therapies
1.3 Market by Application
1.3.1 Global Mental Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Depression
1.3.3 Bipolar Disorder
1.3.4 Schizophrenia
1.3.5 Dementia
1.3.6 Post-traumatic Stress Disorder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mental Disorder Treatment Market Perspective (2016-2027)
2.2 Mental Disorder Treatment Growth Trends by Regions
2.2.1 Mental Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mental Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mental Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mental Disorder Treatment Industry Dynamic
2.3.1 Mental Disorder Treatment Market Trends
2.3.2 Mental Disorder Treatment Market Drivers
2.3.3 Mental Disorder Treatment Market Challenges
2.3.4 Mental Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mental Disorder Treatment Players by Revenue
3.1.1 Global Top Mental Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Mental Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mental Disorder Treatment Revenue
3.4 Global Mental Disorder Treatment Market Concentration Ratio
3.4.1 Global Mental Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mental Disorder Treatment Revenue in 2020
3.5 Mental Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Mental Disorder Treatment Product Solution and Service
3.7 Date of Enter into Mental Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mental Disorder Treatment Breakdown Data by Type
4.1 Global Mental Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mental Disorder Treatment Forecasted Market Size by Type (2022-2027)
5 Mental Disorder Treatment Breakdown Data by Application
5.1 Global Mental Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mental Disorder Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mental Disorder Treatment Market Size (2016-2027)
6.2 North America Mental Disorder Treatment Market Size by Type
6.2.1 North America Mental Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Mental Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Mental Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Mental Disorder Treatment Market Size by Application
6.3.1 North America Mental Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Mental Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Mental Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Mental Disorder Treatment Market Size by Country
6.4.1 North America Mental Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Mental Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mental Disorder Treatment Market Size (2016-2027)
7.2 Europe Mental Disorder Treatment Market Size by Type
7.2.1 Europe Mental Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mental Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mental Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Mental Disorder Treatment Market Size by Application
7.3.1 Europe Mental Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mental Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mental Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Mental Disorder Treatment Market Size by Country
7.4.1 Europe Mental Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mental Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mental Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mental Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Mental Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mental Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mental Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mental Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Mental Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mental Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mental Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mental Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Mental Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mental Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mental Disorder Treatment Market Size (2016-2027)
9.2 Latin America Mental Disorder Treatment Market Size by Type
9.2.1 Latin America Mental Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mental Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mental Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Mental Disorder Treatment Market Size by Application
9.3.1 Latin America Mental Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mental Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mental Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Mental Disorder Treatment Market Size by Country
9.4.1 Latin America Mental Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mental Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mental Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mental Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Mental Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mental Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mental Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mental Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Mental Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mental Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mental Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mental Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Mental Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mental Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Mental Disorder Treatment Introduction
11.1.4 Allergan Plc Revenue in Mental Disorder Treatment Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Mental Disorder Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 VistaGen Therapeutics
11.3.1 VistaGen Therapeutics Company Details
11.3.2 VistaGen Therapeutics Business Overview
11.3.3 VistaGen Therapeutics Mental Disorder Treatment Introduction
11.3.4 VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2016-2021)
11.3.5 VistaGen Therapeutics Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Details
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Mental Disorder Treatment Introduction
11.4.4 Sanofi S.A Revenue in Mental Disorder Treatment Business (2016-2021)
11.4.5 Sanofi S.A Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Details
11.5.2 Novartis International AG Business Overview
11.5.3 Novartis International AG Mental Disorder Treatment Introduction
11.5.4 Novartis International AG Revenue in Mental Disorder Treatment Business (2016-2021)
11.5.5 Novartis International AG Recent Development
11.6 Mylan N.V
11.6.1 Mylan N.V Company Details
11.6.2 Mylan N.V Business Overview
11.6.3 Mylan N.V Mental Disorder Treatment Introduction
11.6.4 Mylan N.V Revenue in Mental Disorder Treatment Business (2016-2021)
11.6.5 Mylan N.V Recent Development
11.7 Amneal Pharmaceuticals LLC
11.7.1 Amneal Pharmaceuticals LLC Company Details
11.7.2 Amneal Pharmaceuticals LLC Business Overview
11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Introduction
11.7.4 Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2016-2021)
11.7.5 Amneal Pharmaceuticals LLC Recent Development
11.8 Cipla Ltd
11.8.1 Cipla Ltd Company Details
11.8.2 Cipla Ltd Business Overview
11.8.3 Cipla Ltd Mental Disorder Treatment Introduction
11.8.4 Cipla Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
11.8.5 Cipla Ltd Recent Development
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Sun Pharmaceutical Industries Ltd Company Details
11.9.2 Sun Pharmaceutical Industries Ltd Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Introduction
11.9.4 Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Ltd Recent Development
11.10 Glenmark Pharmaceuticals Limited
11.10.1 Glenmark Pharmaceuticals Limited Company Details
11.10.2 Glenmark Pharmaceuticals Limited Business Overview
11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Introduction
11.10.4 Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2016-2021)
11.10.5 Glenmark Pharmaceuticals Limited Recent Development
11.11 Lupin Limited
11.11.1 Lupin Limited Company Details
11.11.2 Lupin Limited Business Overview
11.11.3 Lupin Limited Mental Disorder Treatment Introduction
11.11.4 Lupin Limited Revenue in Mental Disorder Treatment Business (2016-2021)
11.11.5 Lupin Limited Recent Development
11.12 Janssen Pharmaceutica
11.12.1 Janssen Pharmaceutica Company Details
11.12.2 Janssen Pharmaceutica Business Overview
11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Introduction
11.12.4 Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2016-2021)
11.12.5 Janssen Pharmaceutica Recent Development
11.13 Bristol Myers Squibb
11.13.1 Bristol Myers Squibb Company Details
11.13.2 Bristol Myers Squibb Business Overview
11.13.3 Bristol Myers Squibb Mental Disorder Treatment Introduction
11.13.4 Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2016-2021)
11.13.5 Bristol Myers Squibb Recent Development
11.14 Sumitomo Dainippon Pharma Co., Ltd
11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.14.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Introduction
11.14.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
11.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Mental Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications
Table 3. Key Players of Self-help Therapies
Table 4. Global Mental Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Mental Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mental Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Mental Disorder Treatment Market Share by Regions (2016-2021)
Table 8. Global Mental Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Mental Disorder Treatment Market Share by Regions (2022-2027)
Table 10. Mental Disorder Treatment Market Trends
Table 11. Mental Disorder Treatment Market Drivers
Table 12. Mental Disorder Treatment Market Challenges
Table 13. Mental Disorder Treatment Market Restraints
Table 14. Global Mental Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Mental Disorder Treatment Market Share by Players (2016-2021)
Table 16. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Disorder Treatment as of 2020)
Table 17. Ranking of Global Top Mental Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Mental Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mental Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Mental Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Mental Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Mental Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Mental Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Mental Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Mental Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Mental Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Mental Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Mental Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Mental Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Mental Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Mental Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Mental Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Mental Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Mental Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Mental Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Mental Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Mental Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Mental Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mental Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mental Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mental Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Mental Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Mental Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Mental Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Mental Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Mental Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Mental Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Mental Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Mental Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mental Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mental Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mental Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Mental Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan Plc Company Details
Table 62. Allergan Plc Business Overview
Table 63. Allergan Plc Mental Disorder Treatment Product
Table 64. Allergan Plc Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 65. Allergan Plc Recent Development
Table 66. Eli Lilly and Company Company Details
Table 67. Eli Lilly and Company Business Overview
Table 68. Eli Lilly and Company Mental Disorder Treatment Product
Table 69. Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 70. Eli Lilly and Company Recent Development
Table 71. VistaGen Therapeutics Company Details
Table 72. VistaGen Therapeutics Business Overview
Table 73. VistaGen Therapeutics Mental Disorder Treatment Product
Table 74. VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 75. VistaGen Therapeutics Recent Development
Table 76. Sanofi S.A Company Details
Table 77. Sanofi S.A Business Overview
Table 78. Sanofi S.A Mental Disorder Treatment Product
Table 79. Sanofi S.A Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 80. Sanofi S.A Recent Development
Table 81. Novartis International AG Company Details
Table 82. Novartis International AG Business Overview
Table 83. Novartis International AG Mental Disorder Treatment Product
Table 84. Novartis International AG Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis International AG Recent Development
Table 86. Mylan N.V Company Details
Table 87. Mylan N.V Business Overview
Table 88. Mylan N.V Mental Disorder Treatment Product
Table 89. Mylan N.V Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 90. Mylan N.V Recent Development
Table 91. Amneal Pharmaceuticals LLC Company Details
Table 92. Amneal Pharmaceuticals LLC Business Overview
Table 93. Amneal Pharmaceuticals LLC Mental Disorder Treatment Product
Table 94. Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 95. Amneal Pharmaceuticals LLC Recent Development
Table 96. Cipla Ltd Company Details
Table 97. Cipla Ltd Business Overview
Table 98. Cipla Ltd Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 99. Cipla Ltd Recent Development
Table 100. Sun Pharmaceutical Industries Ltd Company Details
Table 101. Sun Pharmaceutical Industries Ltd Business Overview
Table 102. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product
Table 103. Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 104. Sun Pharmaceutical Industries Ltd Recent Development
Table 105. Glenmark Pharmaceuticals Limited Company Details
Table 106. Glenmark Pharmaceuticals Limited Business Overview
Table 107. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product
Table 108. Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 109. Glenmark Pharmaceuticals Limited Recent Development
Table 110. Lupin Limited Company Details
Table 111. Lupin Limited Business Overview
Table 112. Lupin Limited Mental Disorder Treatment Product
Table 113. Lupin Limited Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 114. Lupin Limited Recent Development
Table 115. Janssen Pharmaceutica Company Details
Table 116. Janssen Pharmaceutica Business Overview
Table 117. Janssen Pharmaceutica Mental Disorder Treatment Product
Table 118. Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 119. Janssen Pharmaceutica Recent Development
Table 120. Bristol Myers Squibb Company Details
Table 121. Bristol Myers Squibb Business Overview
Table 122. Bristol Myers Squibb Mental Disorder Treatment Product
Table 123. Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 124. Bristol Myers Squibb Recent Development
Table 125. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 126. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 127. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product
Table 128. Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2016-2021) & (US$ Million)
Table 129. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mental Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medications Features
Figure 3. Self-help Therapies Features
Figure 4. Global Mental Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 5. Depression Case Studies
Figure 6. Bipolar Disorder Case Studies
Figure 7. Schizophrenia Case Studies
Figure 8. Dementia Case Studies
Figure 9. Post-traumatic Stress Disorder Case Studies
Figure 10. Others Case Studies
Figure 11. Mental Disorder Treatment Report Years Considered
Figure 12. Global Mental Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Mental Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Mental Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Mental Disorder Treatment Market Share by Regions (2022-2027)
Figure 16. Global Mental Disorder Treatment Market Share by Players in 2020
Figure 17. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Disorder Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Mental Disorder Treatment Revenue in 2020
Figure 19. Global Mental Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Mental Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Mental Disorder Treatment Market Share by Type (2016-2027)
Figure 23. North America Mental Disorder Treatment Market Share by Application (2016-2027)
Figure 24. North America Mental Disorder Treatment Market Share by Country (2016-2027)
Figure 25. United States Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Mental Disorder Treatment Market Share by Type (2016-2027)
Figure 29. Europe Mental Disorder Treatment Market Share by Application (2016-2027)
Figure 30. Europe Mental Disorder Treatment Market Share by Country (2016-2027)
Figure 31. Germany Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Mental Disorder Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Mental Disorder Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Mental Disorder Treatment Market Share by Region (2016-2027)
Figure 41. China Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Mental Disorder Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Mental Disorder Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Mental Disorder Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Mental Disorder Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Mental Disorder Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Mental Disorder Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Mental Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Plc Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 62. VistaGen Therapeutics Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 63. Sanofi S.A Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 64. Novartis International AG Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 65. Mylan N.V Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 66. Amneal Pharmaceuticals LLC Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 67. Cipla Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 68. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 69. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 70. Lupin Limited Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 71. Janssen Pharmaceutica Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 72. Bristol Myers Squibb Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 73. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…- 世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年） Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…
- 世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年） Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened…
- 世界の心的外傷後ストレス障害（PTSD）市場規模・現状・予測（2021年-2027年） Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened…
- 世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…